Oncology
Conference Coverage
Research Highlights From ESMO Breast Cancer
An international panel provided insights on notable breast cancer research.
Feature
Does More Systemic Treatment for Advanced Cancer Improve Survival?
Researchers evaluate whether patients treated in practices with higher rates of systemic therapy for very advanced disease have longer survival....
Latest News
Merkel Cell: Immunotherapy Not Used for Many Patients With Metastatic Disease
In the study, those who received immunotherapy had a 35% decrease in the risk for death per year compared with those who did not.
Latest News
Use of Radiotherapy for Nonmelanoma Skin Cancer Increasing, Study Finds
“There has been recent growth in the use of radiotherapy despite this being a secondary option in skin cancer, primarily when surgery is...
Feature
Urine Tests Could Be ‘Enormous Step’ in Diagnosing Cancer
Cancer biomarkers in urine are not nearly as widely studied as those in the blood, but a new wave of urine tests suggests research is gaining pace...
Conference Coverage
ART Safe for Breast Cancer Survivors with BRCA1/2 Mutations
Researchers compare maternal and fetal outcomes between those who conceived spontaneously versus those using ART in this high-risk population
Feature
Chatbots Seem More Empathetic Than Docs in Cancer Discussions
AI gives readable, high quality, and empathetic responses to social media queries about cancer.
Feature
Outside the Guidelines: Prostate Cancer Screening Overused in Older Men
Experts address potential harms of screening for prostate cancer in patients with low life expectancy.
News from the FDA/CDC
FDA OKs First Multitarget Stool RNA Test for CRC Screening
The FDA approval was based on results of the CRC-PREVENT trial.
Conference Coverage
Oral Microbiome Test Could Detect Gastric Cancer Earlier
A noninvasive “swish and spit” test could be more accessible and allow for more widespread screening.
From the Journals
Hypofractionated Radiotherapy Limits Toxic Effects in Cervical Cancer
Researchers analyze outcomes from patients undergoing hypofractionated IMRT for cervical cancer after radical hysterectomy and pelvic lymph node...